Telemark Asset Management LLC Decreases Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

Telemark Asset Management LLC trimmed its position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 13.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,475,000 shares of the company’s stock after selling 225,000 shares during the period. Telemark Asset Management LLC owned about 2.07% of ASP Isotopes worth $6,682,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of ASP Isotopes during the 3rd quarter valued at about $6,249,000. Charles Schwab Investment Management Inc. raised its holdings in shares of ASP Isotopes by 16.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares in the last quarter. KKM Financial LLC raised its holdings in shares of ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after buying an additional 9,000 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of ASP Isotopes during the 3rd quarter valued at about $52,000. Finally, Corsair Capital Management L.P. purchased a new position in shares of ASP Isotopes during the 3rd quarter valued at about $158,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Price Performance

ASPI opened at $4.11 on Thursday. The stock’s 50 day simple moving average is $5.18 and its 200 day simple moving average is $4.76. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $9.33. The firm has a market cap of $293.41 million, a price-to-earnings ratio of -6.74 and a beta of 3.66.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.